Fifth Third Bancorp decreased its position in ICU Medical, Inc. (NASDAQ:ICUI – Free Report) by 18.9% during the third quarter, according to the company in its most recent disclosure with the SEC. The firm owned 36,190 shares of the medical instruments supplier’s stock after selling 8,408 shares during the quarter. Fifth Third Bancorp’s holdings in ICU Medical were worth $5,809,000 at the end of the most recent quarter.
Other institutional investors and hedge funds have also bought and sold shares of the company. Versant Capital Management Inc boosted its position in ICU Medical by 26.2% in the third quarter. Versant Capital Management Inc now owns 313 shares of the medical instruments supplier’s stock worth $50,000 after purchasing an additional 65 shares during the last quarter. Nisa Investment Advisors LLC grew its stake in shares of ICU Medical by 1.3% during the 3rd quarter. Nisa Investment Advisors LLC now owns 6,088 shares of the medical instruments supplier’s stock valued at $977,000 after purchasing an additional 79 shares during the period. California Public Employees Retirement System increased its position in shares of ICU Medical by 0.3% during the 1st quarter. California Public Employees Retirement System now owns 30,461 shares of the medical instruments supplier’s stock valued at $3,934,000 after purchasing an additional 90 shares during the last quarter. Allworth Financial LP increased its position in shares of ICU Medical by 155.1% during the 2nd quarter. Allworth Financial LP now owns 176 shares of the medical instruments supplier’s stock valued at $26,000 after purchasing an additional 107 shares during the last quarter. Finally, Arizona State Retirement System increased its position in shares of ICU Medical by 1.7% during the 2nd quarter. Arizona State Retirement System now owns 6,551 shares of the medical instruments supplier’s stock valued at $960,000 after purchasing an additional 109 shares during the last quarter. 96.10% of the stock is owned by hedge funds and other institutional investors.
Analyst Ratings Changes
Several equities analysts have recently weighed in on the stock. Wall Street Zen upgraded shares of ICU Medical from a “buy” rating to a “strong-buy” rating in a research note on Saturday, August 8th. BTIG Research boosted their target price on shares of ICU Medical from $170.00 to $200.00 and gave the company a “buy” rating in a research report on Friday, August 7th. Raymond James Financial reaffirmed a “strong-buy” rating and set a $200.00 target price on shares of ICU Medical in a report on Friday, August 7th. Needham & Company LLC upped their target price on shares of ICU Medical from $165.00 to $187.00 and gave the company a “buy” rating in a report on Friday, August 7th. Finally, KeyCorp increased their price target on shares of ICU Medical from $187.00 to $189.00 and gave the stock an “overweight” rating in a research report on Friday, November 6th. Two analysts have rated the stock with a Strong Buy rating, four have assigned a Buy rating and three have issued a Hold rating to the stock. According to data from MarketBeat.com, ICU Medical has an average rating of “Moderate Buy” and an average price target of $195.20.
Insider Buying and Selling
In related news, Director Elisha Finney sold 1,700 shares of the business’s stock in a transaction that occurred on Friday, November 13th. The stock was sold at an average price of $179.00, for a total transaction of $304,300.00. Following the completion of the transaction, the director directly owned 4,871 shares in the company, valued at approximately $871,909. The trade was a 25.87% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, VP Virginia Sanzone sold 4,856 shares of the stock in a transaction that occurred on Thursday, September 3rd. The stock was sold at an average price of $168.69, for a total transaction of $819,158.64. Following the completion of the sale, the vice president directly owned 14,604 shares of the company’s stock, valued at $2,463,548.76. This represents a 24.95% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last quarter, insiders have sold 6,621 shares of company stock valued at $1,135,094. 2.10% of the stock is currently owned by corporate insiders.
ICU Medical Stock Performance
NASDAQ:ICUI opened at $181.87 on Tuesday. The stock has a 50-day simple moving average of $164.01 and a two-hundred day simple moving average of $150.07. ICU Medical, Inc. has a 52-week low of $113.37 and a 52-week high of $192.85. The company has a debt-to-equity ratio of 0.52, a quick ratio of 1.19 and a current ratio of 2.37. The firm has a market capitalization of $4.55 billion, a PE ratio of 76.10, a P/E/G ratio of 2.23 and a beta of 0.88.
ICU Medical (NASDAQ:ICUI – Get Free Report) last issued its quarterly earnings results on Thursday, November 5th. The medical instruments supplier reported $2.44 EPS for the quarter, topping analysts’ consensus estimates of $2.14 by $0.30. ICU Medical had a return on equity of 8.40% and a net margin of 2.76%. The business had revenue of $556.22 million during the quarter, compared to analysts’ expectations of $552.03 million. During the same quarter in the prior year, the business posted $2.03 earnings per share. The business’s quarterly revenue was up 4.4% on a year-over-year basis. Analysts forecast that ICU Medical, Inc. will post 7.22 EPS for the current year.
ICU Medical Company Profile
ICU Medical is a medical technology company that develops, manufactures and markets products used in infusion therapy, vascular access and critical care. Its offerings include infusion pumps and related sets and accessories, IV solutions, needlefree connectors, and products designed to help protect healthcare workers when handling hazardous drugs. Founded in 1984, the company expanded its product portfolio through acquisitions, including the infusion systems business of Hospira in 2017 and Smiths Medical in 2022.
Featured Stories
- Five stocks we like better than ICU Medical
- Ondas Is Building a Defense Growth Engine, But Can It Deliver on Its Backlog?
- Orbiting Growth: Federal Contracts Boost Viasat’s Outlook
- Modine Manufacturing Scales Up to Solve the AI Heat Problem
- Nebius Revenue Is Surging, But Its Spending Is Raising Bigger Questions
Want to see what other hedge funds are holding ICUI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for ICU Medical, Inc. (NASDAQ:ICUI – Free Report).
Receive News & Ratings for ICU Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical and related companies with MarketBeat.com's FREE daily email newsletter.
